If you’re in your 30s, 40s or 50s, dementia might feel like a distant concern, something you associate with advanced age.

Alzheimer’s disease is characterized by a host of recognizable cognitive symptoms, but many non-cognitive symptoms like changes in sleep, anxiety and depression can be early signs of the disease.

Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

An experimental drug reduced the risk of developing symptoms of Alzheimer's disease by half in people with a rare genetic ...

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...

A study examining the long-term effects of anti-amyloid therapy gantenerumab suggests that full amyloid plaque removal may help reduce Alzheimer’s symptoms in individuals at risk for dominantly ...

Washington University School of Medicine led a study evaluating long-term gantenerumab treatment in individuals with dominantly inherited Alzheimer's disease (DIAD). Gantenerumab was associated with ...

While research has determined that there is no association between having AMD and then developing Alzheimer's or dementia, ...

A new international study has offered hope that Alzheimer’s disease may one day be preventable—at least in people genetically ...

An experimental treatment appears to delay Alzheimer’s symptoms in some people genetically destined to get the disease in ...